226 related articles for article (PubMed ID: 24527518)
1. [Efficacy and safety of moxifloxacin in patients with nursing and healthcare-associated pneumonia].
Yamasaki K; Yatera K; Kawanaml T; Suzuki Y; Choujin Y; Akata K; Ogoshi T; Tokuyama S; Nagata S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Kawajiri T; Obata H; Awaya Y; Yoshii C; Mukae H
Jpn J Antibiot; 2013 Oct; 66(5):283-92. PubMed ID: 24527518
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of moxifloxacin tablet on nursing and health care-associated pneumonia--a prospective study with a simple suspension method].
Takaku C; Hidaka T
Jpn J Antibiot; 2013 Apr; 66(2):59-70. PubMed ID: 23951725
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].
Yamasaki K; Yatera K; Kawanami T; Sasahara Y; Hata R; Uchimura K; Tachiwada T; Naito K; Kato K; Takaki T; Shimabukuro I; Shiraishi T; Oda K; Hara K; Chojin Y; Suzuki Y; Akata K; Ogoshi T; Tokuyama S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Obata H; Awaya Y; Tsuda T; Yoshii C; Mukae H
Jpn J Antibiot; 2014 Feb; 67(1):23-32. PubMed ID: 24809206
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study of the Efficacy, Safety and Pharmacokinetics of Enteral Moxifloxacin in the Treatment of Hemodialysis Patients with Pneumonia.
Tokimatsu I; Shigemura K; Kotaki T; Yoshikawa H; Yamamichi F; Tomo T; Arakawa S; Fujisawa M; Kadota JI
Intern Med; 2017; 56(11):1315-1319. PubMed ID: 28566592
[TBL] [Abstract][Full Text] [Related]
6. Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia.
Solnick JV
Clin Infect Dis; 2006 Jul; 43(1):109; author reply 110-1. PubMed ID: 16758427
[No Abstract] [Full Text] [Related]
7. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.
Portier H; Brambilla C; Garre M; Paganin F; Poubeau P; Zuck P
Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):367-76. PubMed ID: 15944847
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.
Hoeffken G; Talan D; Larsen LS; Peloquin S; Choudhri SH; Haverstock D; Jackson P; Church D
Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):772-5. PubMed ID: 15605184
[TBL] [Abstract][Full Text] [Related]
10. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects.
Bassetti M; Rosso R; Tosi C; DI Biagio A; Righi E; Viscoli C
J Chemother; 2007 Feb; 19(1):104-5. PubMed ID: 17309861
[No Abstract] [Full Text] [Related]
12. [Efficacy and safety of azithromycin infusion in patients with mild or moderate community-acquired pneumonia].
Noguchi S; Yatera K; Kawanami T; Yamasaki K; Uchimura K; Hata R; Tachiwada T; Oda K; Hara K; Suzuki Y; Akata K; Ogoshi T; Tokuyama S; Inoue N; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Obata H; Tsuda T; Yoshii C; Mukae H
Jpn J Antibiot; 2014 Jun; 67(3):193-203. PubMed ID: 25163252
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.
Katz E; Larsen LS; Fogarty CM; Hamed K; Song J; Choudhri S
J Emerg Med; 2004 Nov; 27(4):395-405. PubMed ID: 15498622
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with moxifloxacin in patients with respiratory tract infections.
Faich GA; Morganroth J; Whitehouse AB; Brar JS; Arcuri P; Kowalsky SF; Haverstock DC; Celesk RA; Church DA
Ann Pharmacother; 2004 May; 38(5):749-54. PubMed ID: 15026565
[TBL] [Abstract][Full Text] [Related]
15. Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.
Yuan X; Liang BB; Wang R; Liu YN; Sun CG; Cai Y; Yu XH; Bai N; Zhao TM; Cui JC; Chen LA
J Chemother; 2012 Oct; 24(5):257-67. PubMed ID: 23182045
[TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin--a new fluoroquinolone antibacterial.
Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?
Ludlam HA; Enoch DA
Int J Antimicrob Agents; 2008 Aug; 32(2):101-5. PubMed ID: 18571380
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolones in the management of community-acquired pneumonia in primary care.
Wispelwey B; Schafer KR
Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291
[TBL] [Abstract][Full Text] [Related]
19. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
20. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).
Ferrara AM
Clin Interv Aging; 2007; 2(2):179-87. PubMed ID: 18044134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
